NeuroOne
Eden Prairie, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into NeuroOne
882 people in our graph share verified history with the NeuroOne team — schools, employers, funds. One of them is your warm intro.
Hanson S. Gifford, IIIunlockedknows Steve Mertens · together at Nuvaira (overlapped)
×2knows the team · via Cardiovascular Systems, Inc.
knows the team · via CR Bard
knows the team · via St. Jude Medical
knows the team · via Universidad Nacional de Colombia
×4knows the team · via Neuro Event Labs Oy
NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.
Founders & leadership
DR

Dave RosaPresident & Chief Executive OfficerHe has three decades of experience in the medical device industry, including senior roles at C.R. Bard, Boston Scientific, and St. Jude Medical in marketing, product development, and business development; he holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.
DW

David WambeckeChief Business Officer
CV

Chris VolkerChief Financial OfficerChris Volker held general management and corporate development roles in medtech, healthcare, and technology companies, with experience in mergers and acquisitions, private equity investments, and strategic partnerships. He has served on boards and in functional leadership across quality, marketing, reimbursement, and human resources.
SM

Steve MertensChief Technology OfficerSteve Mertens is Chief Technology Officer at NeuroOne, which develops neurotechnology combining medical devices and artificial intelligence. He has experience in research, product development, manufacturing, and commercialization across startup and large-company environments.
CD

Camilo Diaz-BotiaVice President of EngineeringCamilo Diaz-Botia brings seven years of neural engineering experience focused on implantable medical devices, with expertise in microfabrication design and integrated systems development. He is Vice President of Engineering at NeuroOne, a neurotechnology company combining medical devices and artificial intelligence.
MC

Mark ChristiansonCo-Founder, VP of Business DevelopmentServes as VP of Business Development at the company he co-founded in 2016. His earlier career includes North American technical sales management at Cortec Corporation, business development at Robert Half Technology, and a regional medical device sales role at PMT Corporation.
WF
Wade FredricksonNamed on SEC filing
SK
Suraj KaliaNamed on SEC filing
JM

Jeff MathiesenNamed on SEC filing
PB

Paul BuckmanNamed on SEC filing
TB
Thomas BachinskiNamed on SEC filing
Investors · 1
FundRxreportedPalo Alto
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2016
▶$1.5MraisedJun 2017 · 14 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJun 2017 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark ChristiansonExecutive Officer
- Wade FredricksonExecutive Officer
- Suraj KaliaDirector
- Jeff MathiesenDirector
- Paul BuckmanDirector
- Thomas BachinskiExecutive Officer
- David A RosaExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.5M
- Minimum investment
- $50K
- Sales commissions
- $120K
- Placement agents
- Corinthian Partners, L.L.C.
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapRf Surgical24 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Neuroelectrics23 shared keywordsNeuroelectrics develops the Starstim platform, combining EEG monitoring headpieces, cloud-based delivery, and personalized protocols to deliver non-invasive Transcranial Electrical Stimulation (tES) neuromodulation therapy for brain disorders such as depression and epilepsy. It serves patients whose conditions are not controlled by drugs or surgery, as well as neuroscience researchers who use its tools for brain research.
NeuroPace16 shared keywordsNeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Seeking Alpha15 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with NeuroOne for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does NeuroOne do?
- NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.
- Who are NeuroOne's investors?
- NeuroOne's investors include FundRx.
- How much funding has NeuroOne raised?
- NeuroOne has disclosed $1.5M raised across 1 round.
- Where is NeuroOne headquartered?
- NeuroOne is headquartered in Eden Prairie, US.






